Fear of Recurrence and Stopping Immunotherapy
Recruiting · NCT04761328 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Pittsburgh
View the official record on ClinicalTrials.gov →Interventions studied
cognitive behavioral therapy
What this trial is about
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Who can take part
Age range
21 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 21 years and older
- Fluent in English
- Diagnosis of cancer and history of treatment with immunotherapy
Exclusion criteria
- Active suicidal ideation, delusions or hallucinations
Where it is running
1 location listed across 1 US state.
- UPMC Hillman Cancer Centers - Pittsburgh, Pennsylvania, United States